Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate
Clinical trial NCT00955760 · COMPLETED
Trial details
- NCT number
- NCT00955760
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2009-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.